2019 was a fantastic year for David in the MTG finance realm. Here are three major lessons he learned this year, and how you can benefit from his experience.
Bonescythe Sliver
The holidays are in full swing and the new year is right around the corner. And as some of you may know, the stock market has been a bit shaky in the last month or so. But it seems Magic is still doing pretty well during this slightly volatile time. I think a good portion […]
Ultimate Masters has hit the market and thereās already been a lot of movement. The prices of the reprints dropped as they usually do when a set first hits the market. But it seems like the prices have started to rebound a lot quicker this time around. Thereās a slight possibility they could drop again […]
This is the first article from my new series, MTG Questions. You might be familiar with the Hold āEm & Fold āEm series (rebranded as MTG Metagame Finance), which takes a tournament-oriented perspective. I decided to start this series to focus on more general aspects of MTG finance. The two seriesĀ will work together, as when […]
Welcome back, folks. It’s been a while since I last wrote an article, in large part because I’ve been unwilling to make any financial moves on MTGO before reading the December 6th announcement about competitive play on Arena. What is announced there could have major ramifications for investing on MTGO, and so I’ve been very […]
This one is bound to be a casual favorite, and it just might have legs in Modern. Or hooks.
Chaz provides QS Insiders a comprehensive Modern Masters 2015 Non-Reprint List. Be sure to document these on Trader Tools!
The full spoiler is now up, and some of the cards bear discussion and some will warrant their own entry. Painting with broad strokes for now, let’s get through the relevant bits from the last of the spoiler. Venom Sliver Deathtouch seems like a really odd ability. Since all of your slivers grant other slivers […]
Mike Lanigan looks a potent card advantage engine particularly suited to tribal decks. Is this the tool Slivers was lacking to be competitive?
Everyone has an opinion these days–buy this, sell that! But actions speak louder than words. This week Sigmund discusses some of his specific holdings to highlight where he is investing.
Casual staples are low-risk specs that almost always jump a bit. Corbin Hosler examines his picks from last year to see how they fared and offers similar picks from M14.